Silver tube coatings in pneumonia prevention
1Virginia Hospital Center, Arlington, USA.
Background:
Ventilator-associated pneumonia (VAP) is a common hospital-acquired infection that is associated with higher mortality rates, increased healthcare costs and longer hospitalisations. One intervention that has recently been used to reduce the prevalence of VAP is a new type of endotracheal tube impregnated with silver sulfadiazine.
Aim:
To investigate whether the use of silver-coated endotracheal tubes reduces VAP in adult intubated patients.
Method:
A thorough evidence-based literature review was conducted to investigate whether the use of silver-coated endotracheal tubes reduces the incidence of VAP. The following databases were consulted: CINAHL; Medline; Health Source: Nursing and Academic edition; ProQuest Nursing and Allied Health Source; Cochrane Database of Systematic Reviews; TRIP Database; and National Guideline Clearinghouse.
Results:
The use of silver-coated endotracheal tubes reduces the prevalence of VAP in intubated patients but should not be used as an isolated intervention.
Conclusion:
More research is needed to assess whether the benefits of silver-coated endotracheal tubes, coupled with additional VAP prevention strategies, outweigh the costs incurred.
More Related Videos
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...


